Your browser doesn't support javascript.
loading
Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune-related adverse event reveal upregulation of toll-like receptor 4/complement-induced innate immune response and increased density of TH 1 T-cells.
Marques-Piubelli, Mario L; Seervai, Riyad N H; Mudaliar, Kumaran M; Ma, Wencai; Milton, Denái R; Wang, Jing; Muhlbauer, Aaron; Parra, Edwin R; Solis, Luisa M; Nagarajan, Priyadharsini; Speiser, Jodi; Hudgens, Courtney; Cho, Woo Cheal; Aung, Phyu P; Patel, Anisha; Pacha, Omar; Nelson, Kelly C; Tetzlaff, Michael T; Amaria, Rodabe N; Torres-Cabala, Carlos A; Prieto, Victor G; Wistuba, Ignacio I; Curry, Jonathan L.
Afiliação
  • Marques-Piubelli ML; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Seervai RNH; Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas, USA.
  • Mudaliar KM; Department of Molecular & Cellular Biology, Baylor College of Medicine, Houston, Texas, USA.
  • Ma W; Internal Medicine Residency Program, Providence Portland Medical Center, Portland, Oregon, USA.
  • Milton DR; Department of Pathology, Loyola University Medical Center, Maywood, Illinois, USA.
  • Wang J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Muhlbauer A; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Parra ER; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Solis LM; Department of Pathology, Loyola University Medical Center, Maywood, Illinois, USA.
  • Nagarajan P; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Speiser J; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Hudgens C; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Cho WC; Department of Pathology, Loyola University Medical Center, Maywood, Illinois, USA.
  • Aung PP; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Patel A; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Pacha O; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Nelson KC; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Tetzlaff MT; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Amaria RN; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Torres-Cabala CA; Departments of Pathology and Dermatology, Oral Pathology and Dermatopathology Unit, The University of California San Francisco, San Francisco, California, USA.
  • Prieto VG; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wistuba II; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Curry JL; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
J Cutan Pathol ; 50(7): 661-673, 2023 Jul.
Article em En | MEDLINE | ID: mdl-37150813

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Penfigoide Bolhoso Limite: Humans Idioma: En Revista: J Cutan Pathol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Penfigoide Bolhoso Limite: Humans Idioma: En Revista: J Cutan Pathol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos